Givaudan's Results Should Provide Some Relief -- Market Talk

Dow Jones
01/29

1015 GMT - Givaudan's full-year results should provide some relief from negative sentiment around the sector amid fears of consumer slowdown, Vontobel analyst Arben Hasanaj says in a research note. The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients showed more volatile top-line trends at the end of 2025, but with diversification paying off and some improvement in the last quarter, the analyst says. "We remain constructive on 2026 given Givaudan's differentiated position and abating cost headwinds," Hasanaj says. The company's current valuation is overly negative in light of the company's potential for value creation, he adds. Shares trade 5.9% lower at 2,953 Swiss francs. (nina.kienle@wsj.com)

 

(END) Dow Jones Newswires

January 29, 2026 05:15 ET (10:15 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10